Finoriq research workspace
ACHIEVE LIFE SCIENCES, INC. (ACHV) Historical Metrics
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes. Review ACHV fundamentals, ratios, and historical filing metrics on Finoriq.
Company Snapshot
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
- Company
- ACHIEVE LIFE SCIENCES, INC. (ACHV)
- Ticker
- ACHV
- Market Cap
- $639.6M
- Latest Price
- $6.23
- Industry
- Diagnostics
ACHIEVE LIFE SCIENCES, INC. (ACHV) Current Valuation Metrics
Static valuation preview for ACHIEVE LIFE SCIENCES, INC. (ACHV). Market data retrieved 2026-07-09. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| Earnings YieldLatest TTM net income divided by market cap. | -8.0% | Net Income | TTM Q1 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -7.0% | Operating Cash Flow | TTM Q1 2026 |
| Price / BookMarket cap divided by stockholders' equity. | 61.0x | Stockholders' Equity | Q1 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.